Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1036745-17-1

C16H13BrN4O is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1036745-17-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1036745-17-1 Structure

  • Basic information

    1. Product Name: C16H13BrN4O
    2. Synonyms: C16H13BrN4O
    3. CAS NO:1036745-17-1
    4. Molecular Formula:
    5. Molecular Weight: 357.209
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1036745-17-1.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C16H13BrN4O(CAS DataBase Reference)
    10. NIST Chemistry Reference: C16H13BrN4O(1036745-17-1)
    11. EPA Substance Registry System: C16H13BrN4O(1036745-17-1)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1036745-17-1(Hazardous Substances Data)

1036745-17-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1036745-17-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,6,7,4 and 5 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1036745-17:
(9*1)+(8*0)+(7*3)+(6*6)+(5*7)+(4*4)+(3*5)+(2*1)+(1*7)=141
141 % 10 = 1
So 1036745-17-1 is a valid CAS Registry Number.

1036745-17-1Relevant articles and documents

Discovery of 2-arylquinazoline derivatives as a new class of ASK1 inhibitors

Monastyrskyi, Andrii,Bayle, Simon,Quereda, Victor,Grant, Wayne,Cameron, Michael,Duckett, Derek,Roush, William

, p. 400 - 404 (2018)

The development of a new series of apoptosis signal-regulating kinase 1 (ASK1) inhibitors is described. Starting from purine, pyrimidine and quinazoline scaffolds identified by high throughput screening, we used tools of structure-based drug design to develop a series of potent kinase inhibitors, including 2-arylquinazoline derivatives 12 and 23, with submicromolar inhibitory activities against ASK1. Kinetic analysis demonstrated that the 2-arylquinazoline scaffold ASK1 inhibitors described herein are ATP competitive.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1036745-17-1